Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions. At Vero Biotech, our mission is to improve the lives of patients by leading the development of innovative technologies for inhaled NO delivery in the acute care hospital setting and beyond, wherever Nitric Oxide treatment is needed. We strive to exceed customer expectations in terms of safety, efficacy, and growth by focusing on the science, development, and commercialization of our innovations.
Looking for a particular VERO Biotech employee's phone or email?
VERO Biotech Questions
The VERO Biotech annual revenue was $21.1 million in 2026.
Rebecca van Doren is the Vice President Marketing of VERO Biotech.
180 people are employed at VERO Biotech.
VERO Biotech is based in Atlanta, Georgia.
The NAICS codes for VERO Biotech are [32, 334, 33, 325, 3254].
The SIC codes for VERO Biotech are [80, 283, 28, 38, 384].
Top VERO Biotech Employees
-
Rebecca van Doren
Vice President Marketing at VERO Biotech
Atlanta, GA, US35 -
Jeffrey Teves
Vice President of Finance at VERO Biotech
Atlanta, GA, US32 -
Shasha Zou
General Counsel at VERO Biotech
Atlanta, GA, US21 -
Lucas Gamero
VP of Engineering at VERO Biotech
Durham, NC, US14 -
Jonathan Powers
Vice President of Manufacturing at VERO Biotech
Woodstock, GA, US22 -
24
-
Migdalia Cruz
Supply Chain Director at VERO Biotech
Atlanta, GA, US35+
Related Companies
